Skip to content
DraconiticResearch
Search Sources API
190,869 studies31 sourcesUpdated 55 min ago
Peer-reviewedCC BY 4.0eClinicalMedicine

Efficacy and tolerability of D-β-hydroxybutyrate ester in patients with amyotrophic lateral sclerosis (KETO-ALS)–a randomised, placebo-controlled, double-blind study

  • Christine Herrmann
  • Luisa Jagodzinski
  • Zeynep Elmas
  • Tabea Herschmann
  • Elke Fröhlich
  • Franziska Bachhuber
  • Tanja Ruschitzka
  • Frank Willkomm
  • Özlem Parlak
  • Ulrike Weiland
  • Felicitas Becker
  • Lars Richter
11 more authors
  • Maximilian Wiesenfarth
  • Zeljko Uzelac
  • Sebastian Michels
  • Simon Witzel
  • Hayrettin Tumani
  • Jochen H. Weishaupt
  • Ludwig Maier
  • Benjamin Mayer
  • Jens Dreyhaupt
  • Joachim Schuster
  • Johannes Dorst
Open at sourceDOICite

Related

  1. Selected traditional Chinese medicines for treating amyotrophic lateral sclerosis: a Bayesian network meta-analysis based on randomised controlled trials
    Chen Shen, Xiao-Ti Wu, Heng Yin +7
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textNeurologyCrossrefEurope PMC
  2. ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD).
    Friederike Ufer, Rosa Rössling, Annika Spottke +11
    TrialsPeer-reviewedCC BYFull textNeurologyEurope PMCCrossrefDOAJ
  3. Transcutaneous Carbon Dioxide Monitoring in Amyotrophic Lateral Sclerosis: A Scoping Review
    Cláudia Santos Silva, Mamede de Carvalho
    European journal of neurologyPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. The value of a family history to distinguish monogenic from polygenic amyotrophic lateral sclerosis
    P. Beele, J. Veldink, W. van Rheenen
    medRxivPreprintAll rights reservedFull textNeurologymedRxiv
  5. Amyotrophic Lateral Sclerosis in a Patient Treated for Neurosyphilis: A Case Report
    Maciej Giecko, Filip Bossowski, Magdalena Bossowska +4
    Neurology internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{herrmann2026efficacy,
  title = {{Efficacy and tolerability of D-β-hydroxybutyrate ester in patients with amyotrophic lateral sclerosis (KETO-ALS)–a randomised, placebo-controlled, double-blind study}},
  author = {Christine Herrmann and Luisa Jagodzinski and Zeynep Elmas and Tabea Herschmann and Elke Fröhlich and Franziska Bachhuber and Tanja Ruschitzka and Frank Willkomm and Özlem Parlak and Ulrike Weiland and Felicitas Becker and Lars Richter and Maximilian Wiesenfarth and Zeljko Uzelac and Sebastian Michels and Simon Witzel and Hayrettin Tumani and Jochen H. Weishaupt and Ludwig Maier and Benjamin Mayer and Jens Dreyhaupt and Joachim Schuster and Johannes Dorst},
  journal = {eClinicalMedicine},
  year = {2026},
  month = oct,
  doi = {10.1016/j.eclinm.2026.104272},
  url = {https://linkinghub.elsevier.com/retrieve/pii/S2589537026005250},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Efficacy and tolerability of D-β-hydroxybutyrate ester in patients with amyotrophic lateral sclerosis (KETO-ALS)–a randomised, placebo-controlled, double-blind study
AU  - Christine Herrmann
AU  - Luisa Jagodzinski
AU  - Zeynep Elmas
AU  - Tabea Herschmann
AU  - Elke Fröhlich
AU  - Franziska Bachhuber
AU  - Tanja Ruschitzka
AU  - Frank Willkomm
AU  - Özlem Parlak
AU  - Ulrike Weiland
AU  - Felicitas Becker
AU  - Lars Richter
AU  - Maximilian Wiesenfarth
AU  - Zeljko Uzelac
AU  - Sebastian Michels
AU  - Simon Witzel
AU  - Hayrettin Tumani
AU  - Jochen H. Weishaupt
AU  - Ludwig Maier
AU  - Benjamin Mayer
AU  - Jens Dreyhaupt
AU  - Joachim Schuster
AU  - Johannes Dorst
PY  - 2026
DA  - 2026/10/30
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.104272
UR  - https://linkinghub.elsevier.com/retrieve/pii/S2589537026005250
SN  - 2589-5370
ER  -